Biological factors influencing response to diuretics in patients with cirrhosis and ascites

被引:0
作者
Lenaerts, A
Codden, T
Henry, JP
Van Cauter, J
Meunier, JC
Ligny, G
机构
[1] Univ Charleroi, CHU Charleroi, Serv Hepatogastroenterol, B-6000 Charleroi, Belgium
[2] CHU Charleroi, Serv Biol Clin, B-6000 Charleroi, Belgium
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2001年 / 25卷 / 03期
关键词
cirrhosis; ascites; renin; aldosterone; sympathetic system; spironolactone; furosemide;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purposes - To examine the biological factors influencing response to diuretics in patients with cirrhosis and ascites. Methods - Sixty-nine patients were evaluated. Patients were classified into 3 groups : group 1 : "good responders" (responding to spironolactone 200 mg/day) group 2 : "bad responders" (responding to spironolactone do; e; above 200 mg/day or requiring of furosemide), and group 3 : "non-responders" (not responding to spironolactone 400 mg/day and furosemide 160 mg/day). Results - There were 30 patients in group 1, 24 in group 2 and 15 in group 3. The degree of activation of the renin-aldosterone and sympathetic system in group 2 was significantly higher than in group I and lower than in group 3. Natriuresis in group 2 (11 +/- 0.7 mEq/24h) was significantly below group 1 (20 +/- 2 mEq/24h) and above group 3 (5 +/- 0.6 mEq/24h). Conclusions - In patients with cirrhosis and ascites, the degree of requiring activation of the renin-aldosterone and sympathetic nervous system influences diuretic response of ascites and is estimated by measured baseline natriuresis.
引用
收藏
页码:268 / 272
页数:5
相关论文
共 23 条
[1]   SYMPATHETIC NERVOUS ACTIVITY, RENIN-ANGIOTENSIN SYSTEM AND RENAL EXCRETION OF PROSTAGLANDIN-E2 IN CIRRHOSIS - RELATIONSHIP TO FUNCTIONAL RENAL-FAILURE AND SODIUM AND WATER-EXCRETION [J].
ARROYO, V ;
PLANAS, R ;
GAYA, J ;
DEULOFEU, R ;
RIMOLA, A ;
PEREZAYUSO, RM ;
RIVERA, F ;
RODES, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1983, 13 (03) :271-278
[2]  
ARROYO V, 1990, ACTA GASTRO-ENT BELG, V53, P249
[3]  
ARROYO V, 1991, OXFORD TXB CLIN HEPA, P429
[4]  
ARROYO V, 1996, HEPATOLOGY, V23, P163
[5]   EFFECTIVENESS OF HIGH-DOSE SPIRONOLACTONE THERAPY IN PATIENTS WITH CHRONIC LIVER-DISEASE AND RELATIVELY REFRACTORY ASCITES [J].
CAMPRA, JL ;
REYNOLDS, TB .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1978, 23 (11) :1025-1030
[6]  
CHANTLER C, 1969, CLIN SCI, V37, P169
[7]  
DESCOS L, 1983, HEPATO-GASTROENTEROL, V30, P15
[8]   SPIRONOLACTONE DIURESIS IN PATIENTS WITH CIRRHOSIS AND ASCITES [J].
EGGERT, RC .
BRITISH MEDICAL JOURNAL, 1970, 4 (5732) :401-&
[9]   MANAGEMENT OF ASCITES AND RENAL-FAILURE IN CIRRHOSIS [J].
FORNS, X ;
GINES, A ;
GINES, P ;
ARROYO, V .
SEMINARS IN LIVER DISEASE, 1994, 14 (01) :82-96
[10]   OPTIMAL DIURETIC REGIMEN FOR CIRRHOTIC ASCITES - CONTROLLED TRIAL EVALUATING SAFETY AND EFFICACY OF SPIRONOLACTONE AND FUROSEMIDE [J].
FULLER, RK ;
KHAMBATTA, PB ;
GOBEZIE, GC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (10) :972-975